Abraxis BioScience Balance Sheet
View: Annual | Quarterly
| Assets | Dec 08 | Dec 07* | Dec 98 |
|---|---|---|---|
| Current Assets | |||
| Cash | 306.4 | 705.1 | -- |
| Net Receivables | 38.9 | 45.9 | -- |
| Inventories | 63.5 | 73.7 | -- |
| Other Current Assets | 400.0 | 52.3 | -- |
| Total Current Assets | 808.8 | 877.0 | -- |
| Net Fixed Assets | 166.7 | 145.1 | -- |
| Other Noncurrent Assets | 463.0 | 480.2 | -- |
| Total Assets | 1,438.6 | 1,502.3 | -- |
| Liabilities and Shareholder's Equity | Dec 08 | Dec 07 | Dec 98 |
| Current Liabilities | |||
| Accounts Payable | 39.1 | 33.6 | -- |
| Short-Term Debt | -- | -- | -- |
| Other Current Liabilities | 383.5 | 108.2 | -- |
| Total Current Liabilities | 422.7 | 141.8 | -- |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 86.4 | 163.1 | -- |
| Total Liabilities | 509.1 | 304.9 | -- |
|
Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 929.5 | 1,197.4 | -- |
| Total Equity | 929.5 | 1,197.4 | -- |
| Shares Outstanding (mil.) | 40.1 | 40.1 | 0.0 |
© 2009 Morningstar, Inc. Financial Data provided by
